Cargando…
BRD4: a general regulator of transcription elongation
Transcription elongation by RNA polymerase II (Pol II) has emerged as a regulatory hub in gene expression. A key control point occurs during early transcription elongation when Pol II pauses in the promoter-proximal region at the majority of genes in mammalian cells and at a large set of genes in Dr...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467588/ https://www.ncbi.nlm.nih.gov/pubmed/36047906 http://dx.doi.org/10.1080/21541264.2022.2108302 |
_version_ | 1784788224449708032 |
---|---|
author | Altendorfer, Elisabeth Mochalova, Yelizaveta Mayer, Andreas |
author_facet | Altendorfer, Elisabeth Mochalova, Yelizaveta Mayer, Andreas |
author_sort | Altendorfer, Elisabeth |
collection | PubMed |
description | Transcription elongation by RNA polymerase II (Pol II) has emerged as a regulatory hub in gene expression. A key control point occurs during early transcription elongation when Pol II pauses in the promoter-proximal region at the majority of genes in mammalian cells and at a large set of genes in Drosophila. An increasing number of trans-acting factors have been linked to promoter-proximal pausing. Some factors help to establish the pause, whereas others are required for the release of Pol II into productive elongation. A dysfunction of this elongation control point leads to aberrant gene expression and can contribute to disease development. The BET bromodomain protein BRD4 has been implicated in elongation control. However, only recently direct BRD4-specific functions in Pol II transcription elongation have been uncovered. This mainly became possible with technological advances that allow selective and rapid ablation of BRD4 in cells along with the availability of approaches that capture the immediate consequences on nascent transcription. This review sheds light on the experimental breakthroughs that led to the emerging view of BRD4 as a general regulator of transcription elongation. |
format | Online Article Text |
id | pubmed-9467588 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-94675882022-09-13 BRD4: a general regulator of transcription elongation Altendorfer, Elisabeth Mochalova, Yelizaveta Mayer, Andreas Transcription Review Transcription elongation by RNA polymerase II (Pol II) has emerged as a regulatory hub in gene expression. A key control point occurs during early transcription elongation when Pol II pauses in the promoter-proximal region at the majority of genes in mammalian cells and at a large set of genes in Drosophila. An increasing number of trans-acting factors have been linked to promoter-proximal pausing. Some factors help to establish the pause, whereas others are required for the release of Pol II into productive elongation. A dysfunction of this elongation control point leads to aberrant gene expression and can contribute to disease development. The BET bromodomain protein BRD4 has been implicated in elongation control. However, only recently direct BRD4-specific functions in Pol II transcription elongation have been uncovered. This mainly became possible with technological advances that allow selective and rapid ablation of BRD4 in cells along with the availability of approaches that capture the immediate consequences on nascent transcription. This review sheds light on the experimental breakthroughs that led to the emerging view of BRD4 as a general regulator of transcription elongation. Taylor & Francis 2022-09-01 /pmc/articles/PMC9467588/ /pubmed/36047906 http://dx.doi.org/10.1080/21541264.2022.2108302 Text en © 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Altendorfer, Elisabeth Mochalova, Yelizaveta Mayer, Andreas BRD4: a general regulator of transcription elongation |
title | BRD4: a general regulator of transcription elongation |
title_full | BRD4: a general regulator of transcription elongation |
title_fullStr | BRD4: a general regulator of transcription elongation |
title_full_unstemmed | BRD4: a general regulator of transcription elongation |
title_short | BRD4: a general regulator of transcription elongation |
title_sort | brd4: a general regulator of transcription elongation |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467588/ https://www.ncbi.nlm.nih.gov/pubmed/36047906 http://dx.doi.org/10.1080/21541264.2022.2108302 |
work_keys_str_mv | AT altendorferelisabeth brd4ageneralregulatoroftranscriptionelongation AT mochalovayelizaveta brd4ageneralregulatoroftranscriptionelongation AT mayerandreas brd4ageneralregulatoroftranscriptionelongation |